We are investigating Intermolecular, Inc. (“Intermolecular” or the “Company”) (IMI) in connection with the proposed acquisition of the Company by Merck KGaA, Darmstadt, Germany. Under the terms of the acquisition agreement, Intermolecular shareholders will receive $1.20 per share.